Precio de cierre
Otros sitios de cotización
|
||
- USD | - |
07/05 | Transcript : Aclaris Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
07/05 | Aclaris Therapeutics, Inc. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024 | CI |
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Therapeutics
90,3
%
| 25 | 85,2 % | 28 | 90,3 % | +11,27 % |
Contract Research
9,7
%
| 17 | 57,2 % | 3 | 9,7 % | -82,15 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 30 | 100,0 % | 31 | 100,0 % | +5,03 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Neal Walker
CEO | Chief Executive Officer | 54 | 01/07/12 |
Kevin Balthaser
DFI | Director of Finance/CFO | 37 | 01/01/17 |
Ajay Aggarwal
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/21 |
Joseph Monahan
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/08/17 |
General Counsel | - | 01/06/18 | |
James Loerop
PRN | Corporate Officer/Principal | 60 | 31/01/22 |
Elaine Morefield
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Andrew Schiff
BRD | Director/Board Member | 58 | 09/08/17 |
Maxine Gowen
BRD | Director/Board Member | 66 | 02/07/19 |
Director/Board Member | 60 | 07/01/20 | |
Director/Board Member | 57 | 01/09/16 | |
Neal Walker
CEO | Chief Executive Officer | 54 | 01/07/12 |
Anand Mehra
BRD | Director/Board Member | 48 | 01/09/14 |
Director/Board Member | 58 | 01/09/14 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 71 264 786 | 69 452 534 ( 97,46 %) | 0 | 97,46 % |
Información de la empresa
Sector
Ventas por actividad
Varia. 1 de ene. | Capi. | |
---|---|---|
+49,41 % | 57,87 mil M | |
+41,65 % | 40,25 mil M | |
-6,72 % | 39,94 mil M | |
-5,96 % | 28,54 mil M | |
+12,99 % | 26,4 mil M | |
-19,82 % | 19,33 mil M | |
+32,35 % | 12,4 mil M | |
-0,08 % | 12,23 mil M | |
+25,18 % | 12,2 mil M |
- Bolsa de valores
- Acciones
- Acción ACRS
- Acción
- Empresa ACLS THER